Healthcare provider profile · identity verified

Thomas W Broughton, M.D.

Family Practice · MONROEVILLE, AL · NPI 1073778023

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	493	110
Amlodipine Besylate	Amlodipine Besylate	331	118
Gabapentin	Gabapentin	276	79
Atorvastatin Calcium	Atorvastatin Calcium	260	89
Furosemide	Furosemide	209	86
Pregabalin	Pregabalin	197	64
Potassium Chloride	Potassium Chloride	196	59
Carvedilol	Carvedilol	178	59
Tramadol Hcl	Tramadol Hcl	178	73
Levofloxacin	Levofloxacin	177	161
Pantoprazole Sodium	Pantoprazole Sodium	168	74
Clonazepam	Clonazepam	154	42
Levothyroxine Sodium	Levothyroxine Sodium	139	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	139	64
Losartan Potassium	Losartan Potassium	130	39
Tamsulosin Hcl	Tamsulosin Hcl	128	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	119	58
Donepezil Hcl	Donepezil Hcl	110	26
Trazodone Hcl	Trazodone Hcl	106	38
Eliquis	Apixaban	98	25
Amoxicillin	Amoxicillin	96	69
Acetaminophen-Codeine	Acetaminophen With Codeine	95	31
Hydrochlorothiazide	Hydrochlorothiazide	95	42
Lisinopril	Lisinopril	92	26
Meloxicam	Meloxicam	92	46
Metformin Hcl	Metformin Hcl	91	34
Omeprazole	Omeprazole	90	34
Zolpidem Tartrate	Zolpidem Tartrate	89	19
Prednisone	Prednisone	87	83
Albuterol Sulfate Hfa	Albuterol Sulfate	86	30
Clopidogrel	Clopidogrel Bisulfate	86	36
Linzess	Linaclotide	83	32
Metoprolol Succinate	Metoprolol Succinate	83	30
Simvastatin	Simvastatin	73	28
Famotidine	Famotidine	67	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	66	62
Tizanidine Hcl	Tizanidine Hcl	64	17
Hydralazine Hcl	Hydralazine Hcl	62	19
Ozempic	Semaglutide	60	suppressed
Duloxetine Hcl	Duloxetine Hcl	59	18
Fluconazole	Fluconazole	59	31
Cephalexin	Cephalexin	57	52
Metoprolol Tartrate	Metoprolol Tartrate	56	21
Ondansetron Hcl	Ondansetron Hcl	56	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	25
Diclofenac Sodium	Diclofenac Sodium	53	22
Memantine Hcl	Memantine Hcl	53	14
Allopurinol	Allopurinol	52	18
Glipizide	Glipizide	52	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	49
Levetiracetam	Levetiracetam	51	16
Pravastatin Sodium	Pravastatin Sodium	48	16
Clonidine Hcl	Clonidine Hcl	47	19
Divalproex Sodium	Divalproex Sodium	47	13
Fluoxetine Hcl	Fluoxetine Hcl	46	14
Ibuprofen	Ibuprofen	46	18
Meclizine Hcl	Meclizine Hcl	46	14
Citalopram Hbr	Citalopram Hydrobromide	45	16
Januvia	Sitagliptin Phosphate	45	suppressed
Mounjaro	Tirzepatide	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	13
Azithromycin	Azithromycin	43	40
Montelukast Sodium	Montelukast Sodium	43	16
Rosuvastatin Calcium	Rosuvastatin Calcium	40	19
Farxiga	Dapagliflozin Propanediol	39	suppressed
Glipizide Er	Glipizide	37	16
Ezetimibe	Ezetimibe	35	11
Nystatin	Nystatin	35	15
Terazosin Hcl	Terazosin Hcl	35	13
Torsemide	Torsemide	35	suppressed
Metolazone	Metolazone	34	14
Warfarin Sodium	Warfarin Sodium	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	29	suppressed
Metronidazole	Metronidazole	29	29
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Spironolactone	Spironolactone	28	suppressed
Glucagon Emergency Kit	Glucagon	27	suppressed
Finasteride	Finasteride	26	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	26	suppressed
Sucralfate	Sucralfate	26	20
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	23	13
Naproxen	Naproxen	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Sodium Chloride	0.9 % Sodium Chloride	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	11
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Baclofen	Baclofen	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Rexulti	Brexpiprazole	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Digoxin	Digoxin	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Lactulose	Lactulose	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fiasp	Insulin Aspart (Niacinamide)	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Colchicine	Colchicine	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Risperidone	Risperidone	11	suppressed
Valsartan	Valsartan	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error